WILSON TROY EDWARD bought RNA
September 5, 2025 · Form 4 insider transaction
WILSON TROY EDWARD bought 14,500 shares of Atrium Therapeutics, Inc. at $12.48 per share, a transaction worth $181.0K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
14,500
Price
$12.48
Total value
$181.0K
InsiderWILSON TROY EDWARD
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 5, 2025
Filing dateSeptember 9, 2025
Shares owned after83,925
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
All exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 4, 2024.